Gene expression profiling of cell lines derived from T-cell malignancies

被引:13
|
作者
Fillmore, GC
Lin, ZS
Bohling, SD
Robetorye, RS
Kim, CH
Jenson, SD
Elenitoba-Johnson, KSJ
Lim, MS
机构
[1] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA
[2] Univ Utah, Hlth Sci Ctr, ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84132 USA
基金
美国国家卫生研究院;
关键词
T-cell; microarray; expression profiling;
D O I
10.1016/S0014-5793(02)02914-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The expression profiles of eight cell lines derived from T-cell malignancies were compared to CD4-positive T-cells using cDNA microarray technology. Unsupervised hierarchical clustering of 4364 genes demonstrated substantial heterogeneity resulting in four distinct groups. While no genes were found to be uniformly up- or down-regulated across all cell lines, we observed 111 over-expressed genes (greater than two-fold) and 1118 down-regulated genes (greater than two-fold) in the lymphomas as a group when compared to CD4-positive T-cells. These included genes involved in cytokine signaling, cell adhesion, cytoskeletal elements, nuclear transcription factors, and known oncogenes and tumor suppressor genes. Quantitative fluorescent reverse transcription-polymerase chain reaction analysis demonstrated 70% concordance with the microarray results. While freshly isolated malignant cells may differ in their individual expression patterns relative to established cell lines from the same diagnoses, we feel that the variety of different lymphocytic cell lines that we examined provides a representative picture of the molecular pathogenesis of T-cell malignancies. (C) 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 50 条
  • [31] Gene expression profiling reveals distinct molecular signatures for nasal NK/T-cell lymphomas and hepatosplenic T-cell lymphomas
    Huang, Y.
    de Reynies, A.
    de Leval, L.
    Rickman, D.
    Gisselbrecht, C.
    Bosq, J.
    Lavergne, A.
    Macintyre, E.
    Brousse, N.
    Marquet, J.
    Schmitt, C.
    Berger, F.
    Gaulard, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 94 - 94
  • [32] Gene expression profiling reveals intrinsic differences between T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma
    Raetz, EA
    Perkins, SL
    Bhojwani, D
    Smock, K
    Philip, M
    Carroll, WL
    Min, DJ
    PEDIATRIC BLOOD & CANCER, 2006, 47 (02) : 130 - 140
  • [33] Adoptive immunotherapy of malignancies with gene modified, EBV-specific, cytotoxic T-cell lines
    Brenner, Malcohn K.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 888 - 888
  • [34] CHARACTERIZATION OF T-CELL LINES AND T-CELL HYBRIDS DERIVED FROM PLASMODIUM-CHABAUDI ADAMI IMMUNE MICE
    BRAKE, D
    LONG, C
    WEIDANZ, W
    FEDERATION PROCEEDINGS, 1985, 44 (04) : 981 - 981
  • [35] Profiling the B/T cell receptor repertoire of lymphocyte derived cell lines
    Kar-Tong Tan
    Ling-Wen Ding
    Qiao-Yang Sun
    Zhen-Tang Lao
    Wenwen Chien
    Xi Ren
    Jin-Fen Xiao
    Xin Yi Loh
    Liang Xu
    Michael Lill
    Anand Mayakonda
    De-Chen Lin
    Henry Yang
    H. Phillip Koeffler
    BMC Cancer, 18
  • [36] Gene profiling in anaplastic large-cell lymphoma-derived cell lines with cDNA expression arrays
    Gaiser, T
    Thorns, C
    Merz, H
    Noack, F
    Feller, AC
    Lange, K
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2002, 11 (02): : 423 - 428
  • [37] HUMAN ALLOGRAFT DERIVED CYTOTOXIC T-CELL LINES
    MICELI, C
    FINN, OJ
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 265 - 265
  • [38] The role of T-cell phenotype and T-cell receptor rearrangement in the diagnosis of T-cell malignancies
    Sorigue, Marc
    Junca, Jordi
    Marce, Silvia
    Cabezon, Marta
    Garcia, Olga
    Zamora, Lurdes
    LEUKEMIA & LYMPHOMA, 2016, 57 (01) : 244 - 246
  • [39] CHARACTERIZATION OF CELL-LINES DERIVED FROM ADULT T-CELL LEUKEMIA AND LYMPHOMA (ATL)
    HARADA, T
    NAGASAKI, M
    KATOH, T
    INOUE, K
    KUBOTA, H
    MORIKAWA, S
    JOURNAL OF LEUKOCYTE BIOLOGY, 1984, 36 (02) : 235 - 236
  • [40] Alemtuzumab in T-cell malignancies
    Claire E. Dearden
    Estella Matutes
    Daniel Catovsky
    Medical Oncology, 2002, 19 : S27 - S32